Audit: definition, pitfalls and advantages ICPC as a tool for family medicine Practical applications of ICPC

Transcription

1 Jean K Soler

2 Jean K Soler

3 Audit: definition, pitfalls and advantages ICPC as a tool for family medicine Practical applications of ICPC

4 The quality of health systems is defined as the level of attainment of health systems intrinsic goals for health improvement and responsiveness to legitimate expectations of the population. (WHO 2001) Clinical audit is a process that has been defined as "a quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit criteria and the implementation of change. (NICE, 2002) NICE. Principles of Best Practice in Clinical Audit WHO. A WHO Framework for Health System Performance Assessment

5

6 Highest standard Realistic and pragmatic

7 Standards often set against evidence base derived from other specialities Outcome measures??? Closing the loop implementing change

8 Quality of health care measured by diseasespecific evidence-based process-of-care guidelines shows primary care performs poorer than more specialised care Primary care achieves similar functional health status at lower cost for chronic disease Primary care achieves better quality, better health, greater equity and lower cost for people and populations Stange K, Ferrer RL. The Paradox of Primary Care. Annals of Family Medicine 2009; 7(4):

9 Potential to improve quality of care Provides evidence of quality of care Due diligence Advantages of empirical approach, when applicable

10 International Classification of Primary Care Its application as a tool for family medicine, for clinical care, practice manegement, audit, and research

11 A - General B - Blood, immune system D - Digestive F - Eye H - Ear (Hearing) K - Circulatory L Musculoskeletal (Locomotion) N - Neurological P - Psychological R - Respiratory S - Skin T - Metabolic, endocrine U - Urological W - Women s health, pregnancy, famil y planning X - Female genital Y - Male genital Z - Social problems

12 1. Complaints and symptoms Code: Diagnostic, screening and preventive Medication, treatment, procedures Test results Administrative Referrals Diagnostic / disease infectious neoplastic injuries congenital anomalies other

13 A B D F H K L N P R S T U W X Y Z

14

15

16 Rubrics code mutually exclusive concepts Inclusion and exclusion criteria: definitions Covers the breadth of the domain Granularity appropriate for the domain Classification based on empirical data

17 Henk Lamberts

18 SYMPTOMS DIAGNOSES ICPC: > 1 PER 1000 PPY ICD: <1 PER 1000 PPY

19 Perceived health problem Perceived need for care RFE, demand for care Diagnosis Process RFE, demand for care Diagnosis Process RFE, demand for care Diagnosis Process

20 Perceived health problem Perceived need for care RFE, demand for care Diagnosis Process RFE, demand for care Diagnosis Process RFE, demand for care Diagnosis Process

21 ICPC (WONCA) Conceptual construct Localisation About health problems and patient complaints Patient centred ICD (WHO) Historical construct Etiologic About diseases Provider centred Marc Jamoulle

22 ICPC and ICD relationships All included in UMLS ICD9 ICPC ICD10 All linked to Snomed-Ct

23 1 year dataframe databases Netherlands Malta Serbia Observation period Patients (cumulative over period) 168,497 49,479 72,673 Patient years denominator 158,370 43,577 72,673 Encounters 838,896 70, ,323 Sub-encounters/Diagnoses 1,178,178 93, ,150 Reasons for encounter (RfE) 1,326, , ,520 RfE in New Episodes of care (EoC) 422,568 82,224 34,828 EoC 554,804 75, ,133 New EoC 337,348 55,821 41,172 Interventions 1,605, , ,468 Prescriptions 810,894 54,352 Measurements and/or test results 252,812 Referrals primary care 28, Referrals specialist 38,250 3,928 Years of observation Number of doctors Practices

24 40 30 NETH POLAND SERBIA JAPAN MALTA A B D F H K L N P R S T U W X Y Z

25 40 NETH JAPAN POLAND MALTA SERBIA A B D F H K L N P R S T U W X Y Z

26 ... because of the added accuracy of the Episode of Care data model; where more than one encounter for the same problem is only counted once (as appropriate)

27

28 Useful to report what we do Less useful to individual patients in our practice

29 The Netherlands Malta Serbia Incidence Prevalence Incidence Prevalence Incidence Prevalence Diagnosis Rate Standardised Rate Standardised Rate Standardised Rate Standardised Rate Standardised Rate Standardised T90 - diabetes type II K86 - hypertension U95 - renal stone D98 - cholecystits/lithiasis S70 - herpes zoster A72 - chicken pox P70 - dementia P72 - schizophrenia All chapter P component All chapter P All chapter S All chapter K

30 Diabetes Prevalence All non standardised data 250 Rates per Belgium UK Bham UK Nottm Netherlands France Spain Italy Denmark Malta Age Bands

31 All Dr Assessed Mental Illness Prevalence non standardised data Rate per Belgium UK Bham Netherlands France Spain Denmark Age Bands

32 The Netherlands Malta Serbia Incidence Prevalence Incidence Prevalence Incidence Prevalence Diagnosis Rate Standardised Rate Standardised Rate Standardised Rate Standardised Rate Standardised Rate Standardised All chapter P component All chapter P

33 The Netherlands Malta Serbia Incidence Prevalence Incidence Prevalence Incidence Prevalence Diagnosis Rate Standardised Rate Standardised Rate Standardised Rate Standardised Rate Standardised Rate Standardised All chapter P component All chapter P p 1000 py (Nl) 51.5 p 1000 py (Mt) 61.5 p 1000 py (Sb)

34 All Dr Assessed Mental Illness Prevalence non standardised data Rate per Belgium UK Bham Netherlands France Spain Denmark Age Bands

35

36

37 More direct impact on patient care than epidemiology of disease Information on how I am doing Possibility to close the audit cycle and implement change in my practice

38 Follow up of asthma patients in my practice

39

40 Audit of referrals in my practice

41 Note: component 1 refers to symptom diagnoses (e.g. Back pain ), component 7 refers to disease labels (e.g. Sciatica ) ICPC Chapters: A general; B - blood, immune system; D digestive; F eye; H - ear (hearing); K circulatory; L musculoskeletal; N neurological; P psychological; R respiratory; S skin; T - metabolic, endocrine; U urological; W - women s health, pregnancy, family planning; X - female genital; Y - male genital; Z - social problems.

42 Note: component 1 refers to symptom diagnoses (e.g. Back pain ), component 7 refers to disease labels (e.g. Sciatica ) ICPC Chapters: A general; B - blood, immune system; D digestive; F eye; H - ear (hearing); K circulatory; L musculoskeletal; N neurological; P psychological; R respiratory; S skin; T - metabolic, endocrine; U urological; W - women s health, pregnancy, family planning; X - female genital; Y - male genital; Z - social problems.

43 Audit of prescribing for diabetes in family medicine in Malta

44 Label Total Glibenclamide 5mg tablet Metformine 500mg tablet Gliclazide 80mg tablet mga Zinkinsuline krist 100ie/ml Glibenclamide 2,5mg tablet Metformine 850mg tablet Insuline gew 100ie/ml injvl Insuline isofaan 100ie/ml Insuline gew+iso 30/70ie/ml Insuline gew+iso 10/90ie/ml Zinkinsuline comb 30/70 inj Glimepiride 2mg tablet Acetylsalicylzuur 100mg tab Fluvastatine 20mg capsule Glimepiride 1mg tablet Insuline gew 100ie/ml injvl Glimepiride 4mg tablet Glipizide 5mg tablet Isosorbidedinitr 5mg tablet Perindopril 4mg tablet Total

45 A study of the diagnosis of diabetes in Malta

46

47 The likelihood ratio (LR) summarises the operating characteristics of a diagnostic test It is the amount by which the test updates the prior probability, and reflects the utility of a diagnostic test (Post Prob = Prior Prob X LR) A likelihood ratio of greater than 1 indicates that the test is associated with the presence of the disease, whilst a likelihood ratio of less than 1 indicates that the test result is associated with the absence of the disease Knottnerus JA, Buntinx F (Ed.). (2009). The evidence base of clinical diagnosis. Theory and methods of diagnostic research. 2 nd Edition. Oxford, UK: John Wiley & Sons Ltd. Guyatt and Rennie. (2002). Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. USA: American Medical Association

48 Reason for encounter (* significant) LR+ (95% CI) Malta LR- (95% CI) Malta LR+ (95% CI) Dutch LR- (95% CI) Dutch U02 (Urinary frequency) ( )* ( ) ( )* ( )* T90 (Diabetes type II) T01 (Excessive thirst) ( )* ( )* ( )* ( )* ( )* ( ) ( )* ( )* T08 (Weight loss) ( )* ( ) ( )* ( )* A91 (Abnormal result inv.) A04 (Weakness/ tiredness) ( ( ) ( )* ( ) )* ( ) ( ) ( ) ( )

49 Patient suspects he/she has diabetes Excessive thirst Abnormal results of investigations Weight loss Urinary frequency Not tiredness! Soler JK, Okkes IM Diagnosis of diabetes mellitus in Malta. The contribution of patients reasons for encounter and doctors interventions to the final diagnosis of diabetes. Poster presentation. EGPRN meeting, Tartu, Estonia.

50 The likelihood of a diagnosis in a new episode of care for cough

51 A strong, reliable predictor for the diagnoses: Cough, acute bronchitis, URTI, acute laryngitis/tracheitis Less strong, but reliable predictor of the diagnoses: Sinusitis, pneumonia, influenza, other viral diseases (NOS), whooping cough The absence of cough (as a symptom) is a moderately strong and reliable predictor to exclude the diagnoses: cough, acute bronchitis and tracheitis Its presence allows strong, reliable exclusion of the diagnoses: gastroenteritis, no disease and health promotion/prevention, and less strong exclusion of the diagnosis adverse effects of medication. There is less reliable evidence that cough supports making the diagnosis of COPD, and supports the exclusion of fever and muscle pain as a diagnosis

52 Organised information in record Decision support systems Practice management Easy audit

53 Image to come

54 Image to come

55 This study would not have been possible without the participation of the Transition Project doctors. From the Netherlands: C. van Boven MD, PhD, Franeker; P.H. Dijksterhuis MD, PhD, Wirdum and Olst; A. Groen, MD, Amstelveen; J. de Haan, MD, Franeker; A.M.Honselaar- De Groot MD, Amstelveen; D. Janssen MD, Franeker; T.A.L. Polman MD, Franeker; G.O. Polderman MD, Amstelveen; K.E.I. Stolp MD, Amstelveen; N. Valken MD, Wirdum; M.T.M. Veltman MD, PhD (deceased), Amstelveen; M. Woerdeman MD, Amstelveen. From Malta: Francis Paul Calleja MD, Birkirkara; Carmen Sammut MD, Siggiewi; Mario R Sammut MD MSc, Siggiewi; Daniel Sammut MD, Zabbar; David Sammut MD, Zabbar; Jason Bonnici MD, Zabbar; John Buhagiar MD, Zabbar; Andrew Baldacchino MD, Zabbar. From Serbia: the FDs in the region of Kraljevo, part of the ICRC project.